| 2025/3 | 2026/3 |
| Cash flows from operating activities | | |
| Profit before income taxes | 23,709 | 40,376 |
| Depreciation | 4,464 | 5,307 |
| Impairment losses | - | 2 |
| Amortization of goodwill | 16 | - |
| Increase (decrease) in provision for bonuses for directors (and other officers) | -8 | 70 |
| Increase (decrease) in allowance for doubtful accounts | -183 | -62 |
| Interest and dividend income | -1,549 | -1,460 |
| Interest expenses | 769 | 910 |
| Share of loss (profit) of entities accounted for using equity method | 90 | -39 |
| Loss (gain) on sale of investment securities | -750 | -1,651 |
| Loss (gain) on valuation of investment securities | 241 | 109 |
| Loss (gain) on step acquisitions | - | -385 |
| Gain on bargain purchase | - | -7,797 |
| Gain on reversal of impairment loss | -642 | - |
| Decrease (increase) in trade receivables | -1,036 | -38,871 |
| Decrease (increase) in inventories | 2,356 | -6,960 |
| Increase (decrease) in trade payables | 2,040 | 10,111 |
| Decrease (increase) in accounts receivable - other | -283 | -89 |
| Increase (decrease) in accrued expenses | -270 | 1,066 |
| Decrease (increase) in advance payments to suppliers | -128 | -368 |
| Decrease (increase) in consumption taxes refund receivable | -1,354 | 1,660 |
| Decrease (increase) in other current assets | 241 | -46 |
| Increase (decrease) in other current liabilities | 61 | 1,935 |
| Other, net | 17 | 738 |
| Subtotal | 27,800 | 4,554 |
| Interest and dividends received | 1,555 | 1,472 |
| Interest paid | -784 | -919 |
| Income taxes paid | -3,523 | -7,578 |
| Net cash provided by (used in) operating activities | 25,047 | -2,471 |
| Cash flows from investing activities | | |
| Payments into time deposits | -19,811 | -330 |
| Proceeds from withdrawal of time deposits | 16,579 | 7,564 |
| Purchase of property, plant and equipment | -5,245 | -3,789 |
| Proceeds from sale of property, plant and equipment | 105 | 124 |
| Purchase of intangible assets | -425 | -758 |
| Purchase of shares of subsidiaries resulting in change in scope of consolidation | - | -7,372 |
| Purchase of investment securities | -2,553 | -4,971 |
| Proceeds from sale of investment securities | 1,445 | 6,023 |
| Short-term loan advances | -30 | -0 |
| Long-term loan advances | -10 | -2 |
| Other payments | -359 | -176 |
| Other proceeds | 338 | 223 |
| Net cash provided by (used in) investing activities | -9,967 | -3,466 |
| Cash flows from financing activities | | |
| Increase (decrease) in short-term borrowings | -629 | 53,492 |
| Proceeds from long-term borrowings | - | 100 |
| Repayments of long-term borrowings | -100 | -6,712 |
| Redemption of bonds | - | -5,200 |
| Purchase of treasury shares | -1 | -14,448 |
| Dividends paid | -5,773 | -5,741 |
| Proceeds from share issuance to non-controlling shareholders | 113 | - |
| Other, net | -953 | -1,160 |
| Net cash provided by (used in) financing activities | -7,343 | 20,329 |
| Effect of exchange rate change on cash and cash equivalents | 2,527 | 885 |
| Net increase (decrease) in cash and cash equivalents | 10,263 | 15,277 |
| Cash and cash equivalents at beginning of period | 62,417 | 72,681 |
| Increase (decrease) in cash and cash equivalents resulting from change in scope of consolidation | - | 333 |
| Cash and cash equivalents at end of period | 72,681 | 88,292 |